Q: Hi- would be interested in your analysis of Well vs. Qipt- if you had to choose one today for small cap healthcare
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Please your comments on the recent financing through shares at 20% below market price. Future prospects? Good value at current price?
-
StorageVault Canada Inc. (SVI)
-
AutoCanada Inc. (ACQ)
-
Exco Technologies Limited (XTC)
-
Leon's Furniture Limited (LNF)
-
Tamarack Valley Energy Ltd. (TVE)
-
Chesswood Group Limited (CHW)
-
Reitmans (Canada) Limited (RET.A)
-
Cardinal Energy Ltd. (CJ)
-
North American Construction Group Ltd. (NOA)
-
Hammond Power Solutions Inc. Class A Subordinate Voting Shares (HPS.A)
-
Richelieu Hardware Ltd. (RCH)
-
Data Communications Management Corp. (DCM)
-
Geodrill Limited Ordinary Shares (GEO)
-
ECN Capital Corp. (ECN)
-
Stelco Holdings Inc. (STLC)
-
Atlas Engineered Products Ltd. (AEP)
-
WELL Health Technologies Corp. (WELL)
-
Sagicor Financial Company Ltd. (SFC)
-
Andlauer Healthcare Group Inc. Subordinate Voting Shares (AND)
-
Quipt Home Medical Corp. (QIPT)
-
Propel Holdings Inc. (PRL)
-
ADENTRA Inc. (ADEN)
Q: If you held the following smaller cap stocks in positions of 0.5% to 1.0% of your total stock portfolio, and wanted to reduce the number of holdings by selling several of them and using the money to add to others, which ones would you sell and which ones would you add to: ACQ, ADEN, AEP, AND, CHW, CJ, DCM, ECN, GEO, HPS.A, LNF, NOA, PRL, QIPT, RCH, RET.A, SFC, STLC, SVI, TVE, WELL, XTC. Assume overall portfolio is well diversified so sectors not a consideration, and that this is the riskier part of portfolio, so, higher risk is fine. Would be great if you could pare this list of 22 stocks down to about 10-15. Thanks.
Q: Why would they offer shares at such a hugh discount is it that could give friends shares in the private placemet at low price.
Q: Hi There,
With the stock price down to 7.85 approx due to the bought deal, all things considered would you advise a holder to add to holdings at this time?
Thanks! Rob
With the stock price down to 7.85 approx due to the bought deal, all things considered would you advise a holder to add to holdings at this time?
Thanks! Rob
Q: I've had small positions in these three health providers since Covid. Are they worth keeping?
Q: Hello 5i Team,
Considering the recent rise of VMD share value, would you endorse a switch to the other former PHM spinout, QIPT. How do you rank them in comparison? I see that you are feeling more confident about VMD recently, but recognize that it's considerably more expensive. Thanks, Brad
Considering the recent rise of VMD share value, would you endorse a switch to the other former PHM spinout, QIPT. How do you rank them in comparison? I see that you are feeling more confident about VMD recently, but recognize that it's considerably more expensive. Thanks, Brad
Q: Would you switch out WELL for QIPT? In you answer if you could provide financial metrics of each to support the answer. Thank you.
Q: Hi for growth momentum and overall risk over 1-2 years which of these 2 would you prefer?
Thanks!
Thanks!
Q: Can you comment on the latest deal by this company and its prospects go forward? Would you consider it a buy, sell or hold? Thanks
-
Verde Agritech Ltd. Ordinary Shares (NPK)
-
Eventbrite Inc. Class A (EB)
-
Haivision Systems Inc. (HAI)
-
Quipt Home Medical Corp. (QIPT)
Q: Currently have a small position in QIPT, and considering adding to the position. Have been following the remaining 3 and thinking of adding.
Can you please provide your thoughts and perhaps growth of these companies.
Thanks in advance
Can you please provide your thoughts and perhaps growth of these companies.
Thanks in advance
Q: Does the recent acquisition have a significant impact on QIPTs prospects?
Q: These are all huge losers for me. Is it worth keeping all of them, or lightening up? If so what would you let go?
John
John
Q: Can you provide your thoughts around QIPT's closing of the Senior Credit Facility. How do you like its growth potential and risk/reward profile for future stock potential?
Q: I would like to start a position in one of these two companies. Which one do you think has better upside potential?
Thanks
Thanks
Q: Quarter and future looks bright with new credit facility. View on performance and future prospects?
-
goeasy Ltd. (GSY)
-
Aritzia Inc. Subordinate Voting Shares (ATZ)
-
Converge Technology Solutions Corp. (CTS)
-
Lightspeed Commerce Inc. Subordinate Voting Shares (LSPD)
-
Nuvei Corporation Subordinate Voting Shares (NVEI)
-
Topicus.com Inc. (TOI)
-
Quipt Home Medical Corp. (QIPT)
Q: Looking to reposition out of Oil&Gas. The noted companies have been beaten down. How would you rank for a 3 year horizon. Highest to lowest. Any other names you would add to this list?
Q: Morning
Your opinion on earnings please, I have a small position and want to slowly add to healthcare for the next leg up whenever that might be.
Your opinion on earnings please, I have a small position and want to slowly add to healthcare for the next leg up whenever that might be.
Q: Would appreciate your views on this morning's blockbuster announcement. The SP has been very lethargic over the past year but this could finally move the yardsticks.
CINCINNATI, April 26, 2022 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, is very pleased to announce the execution of a national insurance contract with a top five health insurer in the United States1.
Management Commentary
“The execution of this national insurance contract with the largest commercial payer in the United States is a major milestone for Quipt and serves as a further accelerant to our ambitious long term growth plans. The national contract is expected to be meaningful as we continue to expand into new states, broadening our operating footprint over a much wider geography. When we make an acquisition, we will be able to immediately leverage the national contract, which is extremely powerful in terms of capturing as many eligible patients as possible,” said Greg Crawford, Chairman and CEO of Quipt. “Moreover, we feel there's still a lot of opportunity for us to go after more national contracts, which would provide the opportunity to add additional payers, and we will continue to work with other large commercial payers to help them better understand our strong patient centric model and the benefits to patients and payors alike. The new national insurance contract, extremely favorable demographics, and our robust operating platform, put us in an industry leading position to provide high touch at home clinical respiratory services throughout the country.”
CINCINNATI, April 26, 2022 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, is very pleased to announce the execution of a national insurance contract with a top five health insurer in the United States1.
Management Commentary
“The execution of this national insurance contract with the largest commercial payer in the United States is a major milestone for Quipt and serves as a further accelerant to our ambitious long term growth plans. The national contract is expected to be meaningful as we continue to expand into new states, broadening our operating footprint over a much wider geography. When we make an acquisition, we will be able to immediately leverage the national contract, which is extremely powerful in terms of capturing as many eligible patients as possible,” said Greg Crawford, Chairman and CEO of Quipt. “Moreover, we feel there's still a lot of opportunity for us to go after more national contracts, which would provide the opportunity to add additional payers, and we will continue to work with other large commercial payers to help them better understand our strong patient centric model and the benefits to patients and payors alike. The new national insurance contract, extremely favorable demographics, and our robust operating platform, put us in an industry leading position to provide high touch at home clinical respiratory services throughout the country.”
Q: What is your take on the quarter? Is the company on a cash burn rate or generating free cashflow if you normalize or remove acquisitions? Thanks